Treatment method with SR18662 appreciably reduces growth and proliferation of CRC cells. SR18662 demonstrates enhanced efficacy in minimizing viability of many CRC cell lines. Movement cytometry analysis following SR18662 treatment method demonstrates an increase in cells captured in both S or G2/M phases on the cell cycle and a substantial https://robertu099rjb0.blogdeazar.com/profile